Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.
Avant is an online lending platform that offers alternatives to its clients with safe financial products.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Bright Machines brings together flexible factory robots with intelligent software, production data and machine learning.
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
RapidSOS is an intelligent safety platform that connects devices, apps, and sensors for safety agents.
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Acorns is a financial technology and services company that specializes in automated investments and robo-advice.
Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Ambros Therapeutics is a clinical-stage biotechnology company.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Balyasny Asset Management has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Balyasny Asset Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Pharmaceutical. The firm invests across 26 different industry categories.
Among tracked funding rounds, Tango Therapeutics received $600.0M in a Post-IPO Equity round. Balyasny Asset Management's total known invested capital is $4.4B.
Balyasny Asset Management's average investment size is $100.4M across its portfolio of 42 companies.
Recent Balyasny Asset Management portfolio additions include Expedition Therapeutics, Avant, LB Pharmaceuticals, Jasper Therapeutics, Tango Therapeutics. These companies were founded in 2020 or later.